Am I infected with SARS-CoV-2? Is it one of the dangerous variants? Being able to answer these questions with a single diagnostic test can be decisive for gauging the spread of disease and selecting the right therapy. Researchers tackle this challenge with a new CRISPR discovery they translated into a diagnostic platform.
Scientists have developed a new so-called optogenetic tool that simplifies a standard method in biotechnology: Instead of feeding the bacteria with sugar as commonly done, the researchers can now simply shine light on them.
